We conjugated an anti-fibrotic small molecule to an anti-PV1 (αPV1) antibody and observe substantial reduction in the development of lung fibrosis (compared to an isotype control antibody) in an idiopathic pulmonary fibrosis (IPF) mouse model. Here, PLVAP is linked to pulmonary fibrosis.